XarSmart Analysis

Develop smart city solutions for urban challenges; Facilitate partnerships between public and private sectors; Enhance research collaboration for innovative projects; Support local governments in implementing smart technologies; Promote sustainability through innovative urban planning.

Supported by the Generalitat de Catalunya; Coordinated by the IDIBELL Biomedical Research Institute; Engages in various innovation awards and events.

Main Information

• Information: XarSMART is a Precision Personalized Medicine Network established in 2023, led by the Bellvitge Biomedical Research Institute (IDIBELL) and funded by AGAUR (Generalitat de Catalunya). The network focuses on Advanced Therapy Medicinal Products, MD and IVD, and SaMD, comprising 17 member institutions, 38 research groups, and over 400 researchers. It aims to provide tools for funding searches, promote collaboration, develop skills, and improve the translation of solutions to the National Health System.
• Interests: HEALTH/FITNESS/WELLBEING, VENTURE CAPITAL/INVESTMENT/M&A
• Location: Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B29.2
• Whether tagged as startup: No relevant data.

Contact & Links

• LinkedIn: Connect on LinkedIn
• Twitter: No relevant data.
• Phone Number: No relevant data.
• Email: Email

Key Information

• Growth Stage: No relevant data.
• Country: No relevant data.
• Founding Year: 2023

Company Context

• Company Name: XarSMART
• Company Website: XarSMART Website